Conclusions
In critically ill patients presenting to the emergency department with early septic
shock, EGDT did not reduce all-cause mortality at 90 days. (Funded by the National
Health and Medical Research Council of Australia and the Alfred Foundation; ARISE
ClinicalTrials.gov number, NCT00975793.)
The New